Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain Stephenson

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Thorax|October 16, 2016
Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practiceHelena A White, Robert F Miller, Anton L Pozniak, et al.
The New England Journal of Medicine|October 10, 2008
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1Iain Stephenson, Karl G Nicholson, Katja Hoschler, et al.
ERJ Open Research|April 28, 2022
Latent tuberculosis screening and treatment in HIV: highly acceptable in a prospective cohort studyHelena A White, Hajra Okhai, Amandip Sahota, et al.
The Lancet. Infectious Diseases|March 28, 2025
Disseminated Mycoplasma pneumoniae infection presenting with polyarthritis and endocarditisGeorgia R Layton, James B Veater, Rebecca Thombre, et al.
Vaccine|November 22, 2011
Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International StandardJohn M Wood, Diane Major, Alan Heath, et al.
The Journal of Infection|June 2, 2020
Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19Shirley Sze, Daniel Pan, Caroline M L Williams, et al.
The Journal of Infection|October 15, 2022
Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipientsJoshua Nazareth, Ian Barr, Sheena G Sullivan, et al.
Vaccine|June 30, 2009
Influenza control in the 21st century: Optimizing protection of older adultsArnold S Monto, Filippo Ansaldi, Richard Aspinall, et al.
Vaccine|October 6, 2009
Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulationsKarl G Nicholson, Catherine I Thompson, Jaco M Klap, et al.
The Journal of Infection|February 5, 2020
Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapyShoshanna May, Feza Kurmoo, Mariesa Iliffe, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Thorax|October 16, 2016
Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practiceHelena A White, Robert F Miller, Anton L Pozniak, et al.
The New England Journal of Medicine|October 10, 2008
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1Iain Stephenson, Karl G Nicholson, Katja Hoschler, et al.
ERJ Open Research|April 28, 2022
Latent tuberculosis screening and treatment in HIV: highly acceptable in a prospective cohort studyHelena A White, Hajra Okhai, Amandip Sahota, et al.
The Lancet. Infectious Diseases|March 28, 2025
Disseminated Mycoplasma pneumoniae infection presenting with polyarthritis and endocarditisGeorgia R Layton, James B Veater, Rebecca Thombre, et al.
Vaccine|November 22, 2011
Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International StandardJohn M Wood, Diane Major, Alan Heath, et al.
The Journal of Infection|June 2, 2020
Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19Shirley Sze, Daniel Pan, Caroline M L Williams, et al.
The Journal of Infection|October 15, 2022
Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipientsJoshua Nazareth, Ian Barr, Sheena G Sullivan, et al.
Vaccine|June 30, 2009
Influenza control in the 21st century: Optimizing protection of older adultsArnold S Monto, Filippo Ansaldi, Richard Aspinall, et al.
Vaccine|October 6, 2009
Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulationsKarl G Nicholson, Catherine I Thompson, Jaco M Klap, et al.
The Journal of Infection|February 5, 2020
Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapyShoshanna May, Feza Kurmoo, Mariesa Iliffe, et al.
Pageof 6